In total, 234 investments creating 13,500 new jobs over the next five years, 59% of which were in regional locations ...

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

While first-generation glucagon-like peptide-1 receptor agonists have clearly taken the obesity market by storm, generating billions of dollars for Novo Nordisk A/S and Eli Lilly and Co., several ...

Vaccine executives have — at least publicly — brushed off concerns ... loss drugs that have become hugely popular and supercharged shares of Zepbound maker Eli Lilly & Co. and Denmark’s Novo Nordisk A ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...